One of the biggest challenges facing the U.S. healthcare system is drug shortages, with the potential for year over year growth to exceed 27%. The U.S. Food and Drug Administration’s Drug Shortages Task Force released a report that identified several factors that often converge to create a shortage situation, including: -The lack of incentives for manufacturers to produce low-margin drugs, -The market failing to recognize and reward manufacturers with robust quality control, and -Regulatory and logistic issues that impede the market’s recovery after a shortage. |